β-adrenergic receptor antagonists inhibit vasculogenesis of embryonic stem cells by downregulation of nitric oxide generation and interference with VEGF signalling

Cell and Tissue Research

Volumn 358, Issue 2, 2014, Pages 443-452

  Sharifpanah, Fatemeh ^a   Saliu, Fatjon ^a   Bekhite, Mohamed M ^b,c   Wartenberg, Maria ^b   Sauer, Heinrich ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c Tanta University   (Egypt)

Author keywords

Infantile hemangioma; Nitric oxide; Stem cells; adrenergic receptor; blocker

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ATENOLOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PROPANOLAMINE DERIVATIVE; PROPRANOLOL; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; EMBRYOID BODY; EMBRYONIC STEM CELL; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; TIME;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ATENOLOL; BIOLOGICAL MARKERS; DOWN-REGULATION; EMBRYOID BODIES; EMBRYONIC STEM CELLS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PROPANOLAMINES; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA; S-NITROSO-N-ACETYLPENICILLAMINE; SIGNAL TRANSDUCTION; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84932175575     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-014-1976-8     Document Type: Article

References (40)

1. Andersen IG, Rechnitzer C, Charabi B (2014) Effectiveness of propanolol for treatment of infantile haemangioma. Dan Med J 61:A4776
2. Babaei S, Teichert-Kuliszewska K, Monge JC, Mohamed F, Bendeck MP, Stewart DJ (1998) Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res 82:1007–1015
3. Balakrishnan K, Perkins JA (2010) Management of airway hemangiomas. Expert Rev Respir Med 4:455–462
4. Basile JR, Castilho RM, Williams VP, Gutkind JS (2006) Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci U S A 103:9017–9022
5. Boscolo E, Mulliken JB, Bischoff J (2011) VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma. Am J Pathol 179:2266–2277
6. Callahan AB, Yoon MK (2012) Infantile hemangiomas: A review. Saudi J Ophthalmol 26:283–291
7. Chang J, Most D, Bresnick S, Mehrara B, Steinbrech DS, Reinisch J, Longaker MT, Turk AE (1999) Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg 103:1–9
8. Chisholm KM, Chang KW, Truong MT, Kwok S, West RB, Heerema-McKenney AE (2012) beta-Adrenergic receptor expression in vascular tumors. Mod Pathol 25:1446–1451
9. Cole SW, Sood AK (2012) Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res 18:1201–1206
10. Conrotto P, Valdembri D, Corso S, Serini G, Tamagnone L, Comoglio PM, Bussolino F, Giordano S (2005) Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 105:4321–4329
11. Dai Y, Hou F, Buckmiller L, Fan CY, Saad A, Suen J, Richter GT (2012) Decreased eNOS protein expression in involuting and propranolol-treated hemangiomas. Arch Otolaryngol Head Neck Surg 138:177–182
12. Degl'Innocenti D, Arighi E, Popsueva A, Sangregorio R, Alberti L, Rizzetti MG, Ferrario C, Sariola H, Pierotti MA, Borrello MG (2004) Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching. Oncogene 23:7297–7309
13. Facemire CS, Nixon AB, Griffiths R, Hurwitz H, Coffman TM (2009) Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension 54:652–658
14. Fantin A, Vieira JM, Plein A, Denti L, Fruttiger M, Pollard JW, Ruhrberg C (2013) NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis. Blood 121:2352–2362
15. Gentile C, Muise-Helmericks RC, Drake CJ (2013) VEGF-mediated phosphorylation of eNOS regulates angioblast and embryonic endothelial cell proliferation. Dev Biol 373:163–175
16. Greenberger S, Bischoff J (2013) Pathogenesis of infantile haemangioma. Br J Dermatol 169:12–19
17. Itinteang T, Tan ST, Brasch H, Day DJ (2010) Primitive mesodermal cells with a neural crest stem cell phenotype predominate proliferating infantile haemangioma. J Clin Pathol 63:771–776
18. Itinteang T, Tan ST, Brasch HD, Steel R, Best HA, Vishvanath A, Jia J, Day DJ (2012) Infantile haemangioma expresses embryonic stem cell markers. J Clin Pathol 65:394–398
19. Jozkowicz A, Dulak J, Nigisch A, Funovics P, Weigel G, Polterauer P, Huk I, Malinski T (2004) Involvement of nitric oxide in angiogenic activities of vascular endothelial growth factor isoforms. Growth Factors 22:19–28
20. Khan ZA, Boscolo E, Picard A, Psutka S, Melero-Martin JM, Bartch TC, Mulliken JB, Bischoff J (2008) Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Investig 118:2592–2599
21. Kleinman ME, Greives MR, Churgin SS, Blechman KM, Chang EI, Ceradini DJ, Tepper OM, Gurtner GC (2007) Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol 27:2664–2670
22. Ku DD, Zaleski JK, Liu S, Brock TA (1993) Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265:H586–H592
23. Lange S, Heger J, Euler G, Wartenberg M, Piper HM, Sauer H (2009) Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species. Cardiovasc Res 81:159–168
24. Leaute-Labreze C, Dumas dR, Hubiche T, Boralevi F, Thambo JB, Taieb A (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649–2651
25. Milosevic N, Bekhite MM, Sharifpanah F, Ruhe C, Wartenberg M, Sauer H (2010) Redox stimulation of cardiomyogenesis versus inhibition of vasculogenesis upon treatment of mouse embryonic stem cells with thalidomide. Antioxid Redox Signal 13:1813–1827
26. Nakagami H, Nakagawa N, Takeya Y, Kashiwagi K, Ishida C, Hayashi S, Aoki M, Matsumoto K, Nakamura T, Ogihara T, Morishita R (2006) Model of vasculogenesis from embryonic stem cells for vascular research and regenerative medicine. Hypertension 48:112–119
27. Picard A, Boscolo E, Khan ZA, Bartch TC, Mulliken JB, Vazquez MP, Bischoff J (2008) IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr Res 63:263–267
28. Plein A, Fantin A, Ruhrberg C (2014) Neuropilin regulation of angiogenesis, arteriogenesis and vascular permeability. Microcirculation (in press)
29. Poole TJ, Finkelstein EB, Cox CM (2001) The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn 220:1–17
30. Sauer H, Gunther J, Hescheler J, Wartenberg M (2000) Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals. Am J Pathol 156:151–158
31. Sauer H, Ravindran F, Beldoch M, Sharifpanah F, Jedelska J, Strehlow B, Wartenberg M (2013) alpha2-Macroglobulin enhances vasculogenesis/angiogenesis of mouse embryonic stem cells by stimulation of nitric oxide generation and induction of fibroblast growth factor-2 expression. Stem Cells Dev 22:1443–1454
32. Sharifpanah F, Wartenberg M, Hannig M, Piper HM, Sauer H (2008) Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism. Stem Cells 26:64–71
33. Smoller BR, Apfelberg DB (1993) Infantile (juvenile) capillary hemangioma: a tumor of heterogeneous cellular elements. J Cutan Pathol 20:330–336
34. Stiles JM, Amaya C, Rains S, Diaz D, Pham R, Battiste J, Modiano JF, Kokta V, Boucheron LE, Mitchell DC, Bryan BA (2013) Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma. PLoS ONE 8:e60021
35. Sun Q, Zhou H, Binmadi NO, Basile JR (2009) Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity. J Biol Chem 284:32066–32074
36. Wang K, Zheng J (2012) Signaling regulation of fetoplacental angiogenesis. J Endocrinol 212:243–255
37. Wartenberg M, Gunther J, Hescheler J, Sauer H (1998) The embryoid body as a novel in vitro assay system for antiangiogenic agents. Lab Investig 78:1301–1314
38. Yang H, Zhang Y, Liu Z, Chen P, Ma K, Zhou C (2008) Mouse embryonic stem cell-derived cardiomyocytes express functional adrenoceptors. Biochem Biophys Res Commun 368:887–892
39. Yuan WL, Jin ZL, Wei JJ, Liu ZY, Xue L, Wang XK (2013) Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients. Br J Oral Maxillofac Surg 51:656–661
40. Ziche M, Morbidelli L (2009) Molecular regulation of tumour angiogenesis by nitric oxide. Eur Cytokine Netw 20:164–170